C5840427
influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Delaware/55/2019 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023]
Concept
Cross-maps
Source vocabularies
Atoms not loaded for this concept.
Related concepts
Common questions
What is the UMLS CUI for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Delaware/55/2019 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023]?
influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Delaware/55/2019 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023] is coded as C5840427 in UMLS.
What is UMLS code C5840427?
C5840427 is the UMLS identifier for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Delaware/55/2019 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023]. It is included in the current NLM UMLS Metathesaurus release.
What is the RxNorm mapping for C5840427?
C5840427 maps to RxNorm 2656568.